Court Nixes BMS Block Of Mylan’s Venezuela Atazanavir Exports
This article was originally published in PharmAsia News
Executive Summary
Shortly after Gilead Sciences signed a historic deal with Indian generic companies for supplies of sofosbuvir to over 90 countries, another licensing agreement has reached a flashpoint. Bristol-Myers Squibb and Mylan are in court over rights to export atazanavir to Venezuela, with the first round in favor of Mylan.